Carl Lawyer

569 total citations
18 papers, 464 citations indexed

About

Carl Lawyer is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Microbiology. According to data from OpenAlex, Carl Lawyer has authored 18 papers receiving a total of 464 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Pulmonary and Respiratory Medicine and 5 papers in Microbiology. Recurrent topics in Carl Lawyer's work include Antimicrobial Peptides and Activities (5 papers), Pediatric health and respiratory diseases (3 papers) and Respiratory and Cough-Related Research (2 papers). Carl Lawyer is often cited by papers focused on Antimicrobial Peptides and Activities (5 papers), Pediatric health and respiratory diseases (3 papers) and Respiratory and Cough-Related Research (2 papers). Carl Lawyer collaborates with scholars based in United States. Carl Lawyer's co-authors include Stephen R. Hazelrigg, Kounosuke Watabe, Joseph Henkle, Theresa M. Boley, Mitchell J. Magee, Misako Watabe, Sudha K. Pai, Lanie E. Eagleton, Tomoyuki Mashimo and P T Borgia and has published in prestigious journals such as Annals of Internal Medicine, Clinical Infectious Diseases and FEBS Letters.

In The Last Decade

Carl Lawyer

17 papers receiving 440 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Carl Lawyer 165 160 145 61 60 18 464
Anthony R. Dal Nogare 129 0.8× 17 0.1× 67 0.5× 28 0.5× 74 1.2× 19 383
M. Timonen 61 0.4× 93 0.6× 40 0.3× 26 0.4× 27 0.5× 13 366
Hee Youn Kim 92 0.6× 23 0.1× 79 0.5× 77 1.3× 17 0.3× 47 451
Miguel Cobas 144 0.9× 17 0.1× 55 0.4× 88 1.4× 96 1.6× 18 423
Fumiyuki Kuze 129 0.8× 21 0.1× 58 0.4× 76 1.2× 22 0.4× 33 432
D. Betty Lew 74 0.4× 13 0.1× 118 0.8× 43 0.7× 103 1.7× 28 389
Golding Bird 114 0.7× 12 0.1× 42 0.3× 36 0.6× 69 1.1× 18 359
John Marks 57 0.3× 12 0.1× 59 0.4× 53 0.9× 26 0.4× 19 408
Masayo Kokubo 182 1.1× 11 0.1× 24 0.2× 41 0.7× 9 0.1× 25 335
T Fujimoto 61 0.4× 21 0.1× 34 0.2× 83 1.4× 6 0.1× 23 311

Countries citing papers authored by Carl Lawyer

Since Specialization
Citations

This map shows the geographic impact of Carl Lawyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carl Lawyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carl Lawyer more than expected).

Fields of papers citing papers by Carl Lawyer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carl Lawyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carl Lawyer. The network helps show where Carl Lawyer may publish in the future.

Co-authorship network of co-authors of Carl Lawyer

This figure shows the co-authorship network connecting the top 25 collaborators of Carl Lawyer. A scholar is included among the top collaborators of Carl Lawyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carl Lawyer. Carl Lawyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Bick, Roger J., Brian J. Poindexter, L. Maximilian Buja, et al.. (2007). Nuclear localization of HBD-1 in human keratinocytes.. PubMed. 7. e3–e3. 12 indexed citations
2.
Bhat, Satyanarayan, et al.. (2007). Modulation of the complement system by human beta-defensin 2.. PubMed. 5. e10–e10. 18 indexed citations
3.
Emala, Charles W., Christopher McQuitty, Scott M. Eleff, et al.. (2002). Asthma, Allergy, and Airway Hyperresponsiveness Are Not Linked to the β2-Adrenoceptor Gene. CHEST Journal. 121(3). 722–731. 7 indexed citations
4.
Hazelrigg, Stephen R., Theresa M. Boley, Mitchell J. Magee, Carl Lawyer, & Joseph Henkle. (1998). Comparison of staged thoracoscopy and median sternotomy for lung volume reduction. The Annals of Thoracic Surgery. 66(4). 1134–1138. 33 indexed citations
5.
Watabe, Misako, et al.. (1997). Sequence and Functional Analysis of the 5′-Flanking Region of the Mouse Growth Inhibitory Factor Gene. Cellular and Molecular Neurobiology. 17(2). 235–243. 5 indexed citations
6.
Hazelrigg, Stephen R., Theresa M. Boley, Keith S. Naunheim, et al.. (1997). Effect of Bovine Pericardial Strips on Air Leak After Stapled Pulmonary Resection. The Annals of Thoracic Surgery. 63(6). 1573–1575. 94 indexed citations
7.
Lawyer, Carl, et al.. (1996). Effects of synthetic form of tracheal antimicrobial peptide on respiratory pathogens. Journal of Antimicrobial Chemotherapy. 37(3). 599–604. 15 indexed citations
8.
Hazelrigg, Stephen R., Theresa M. Boley, Joseph Henkle, et al.. (1996). Thoracoscopic laser bullectomy: A prospective study with three-month results. Journal of Thoracic and Cardiovascular Surgery. 112(2). 319–327. 42 indexed citations
9.
Lawyer, Carl, Sudha K. Pai, Misako Watabe, et al.. (1996). Antimicrobial activity of a 13 amino acid tryptophan‐rich peptide derived from a putative porcine precursor protein of a novel family of antibacterial peptides. FEBS Letters. 390(1). 95–98. 133 indexed citations
10.
Lawyer, Carl, Misako Watabe, Sudha K. Pai, et al.. (1996). A synthetic form of tracheal antimicrobial peptide has both bactericidal and antifungal activities.. PubMed. 14(3). 171–8. 3 indexed citations
11.
Rosenfeld, Elaine, et al.. (1996). Potential in vitro activity of Kutapressin against Epstein-Barr virus.. PubMed. 10(3). 313–8.
12.
Ablashi, D. V., Z. N. Berneman, Carl Lawyer, et al.. (1995). Antiviral activity in vitro of Kutapressin against human herpesvirus-6.. PubMed. 8(4). 581–6. 3 indexed citations
13.
Hermann, William J., et al.. (1994). Subjective Reduction in Symptoms of Chronic Fatigue Syndrome Following Long-Term Treatment with a Porcine Liver Extract: A Phase 1 Trial. Clinical Infectious Diseases. 18(Supplement_1). S114–S114. 2 indexed citations
14.
Ablashi, D. V., Zwi Berneman, Carl Lawyer, & Anthony L. Komaroff. (1994). Kutapressin Inhibits In Vitro Infection of Human Herpesvirus Type 6. Clinical Infectious Diseases. 18(Supplement_1). S113–S113. 1 indexed citations
15.
Molyneux, Russell J., Yutian Pan, Joseph E. Tropea, et al.. (1993). 2-Hydroxymethyl-3,4-dihydroxy-6-methylpyrrolidine (6-Deoxy-DMDP), an Alkaloid β-Mannosidase Inhibitor from Seeds of Angylocalyx pynaertii. Journal of Natural Products. 56(8). 1356–1364. 37 indexed citations
16.
Hirshman, Carol A., et al.. (1981). Dyphylline Aerosol Attenuates Antigen-Induced Bronchoconstriction in Experimental Canine Asthma. CHEST Journal. 79(4). 454–458. 2 indexed citations
17.
Lawyer, Carl, et al.. (1980). Utilization of intravenous dihydroxypropyl theophylline (dyphylline) in an aminophylline-sensitive patient, and its pharmacokinetic comparison with theophylline. Journal of Allergy and Clinical Immunology. 65(5). 353–357. 8 indexed citations
18.
Lawyer, Carl, et al.. (1978). Treatment of Theophylline Neurotoxicity with Resin Hemoperfusion. Annals of Internal Medicine. 88(4). 516–517. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026